|
|
|
Insider
Information: |
Canaan Partners Viii Llc |
Relationship: |
10% Owner |
City: |
Westport |
State: |
CT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
4,819,199 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$42,298,951 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
4,819,199 |
|
|
Total
Value |
$42,298,951 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Durata Therapeutics, Inc. |
DRTX |
Director, 10% Owner |
2012-07-24 |
1,902,030 |
2012-07-24 |
0 |
Premium* |
|
Cardlytics Inc |
CDLX |
Director |
2019-08-12 |
0 |
2018-02-13 |
0 |
Premium* |
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2019-12-27 |
2,917,169 |
2018-07-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CDLX |
Cardlytics Inc |
Director |
|
2018-08-09 |
4 |
OE |
$0.00 |
$49 |
D/D |
122,777 |
3,368,141 |
0 |
- |
|
CDLX |
Cardlytics Inc |
Director |
|
2018-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,245,364 |
3,245,364 |
0 |
- |
|
LQDA |
Liquidia Technologies Inc |
10% Owner |
|
2019-12-27 |
4 |
B |
$3.13 |
$999,997 |
D/D |
319,488 |
2,917,169 |
2.45 |
- |
|
LQDA |
Liquidia Technologies Inc |
10% Owner |
|
2019-03-04 |
4 |
OE |
$0.01 |
$344 |
D/D |
34,378 |
2,597,681 |
0 |
- |
|
LQDA |
Liquidia Technologies Inc |
10% Owner |
|
2018-07-30 |
4 |
B |
$11.00 |
$8,000,003 |
D/D |
727,273 |
2,563,303 |
2.45 |
- |
|
CDLX |
Cardlytics Inc |
Director |
|
2018-09-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,000,000) |
2,368,141 |
0 |
- |
|
DRTX |
Durata Therapeutics, Inc. |
Director |
|
2012-07-24 |
4 |
B |
$9.00 |
$4,999,995 |
D/D |
555,555 |
1,902,030 |
3.92 |
- |
|
LQDA |
Liquidia Technologies Inc |
10% Owner |
|
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,833,331 |
1,836,030 |
0 |
- |
|
CDLX |
Cardlytics Inc |
Director |
|
2019-01-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(750,000) |
1,618,141 |
0 |
- |
|
DRTX |
Durata Therapeutics, Inc. |
Director |
|
2012-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,346,475 |
1,346,475 |
0 |
- |
|
CDLX |
Cardlytics Inc |
Director |
|
2019-04-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(485,000) |
1,133,141 |
0 |
- |
|
CDLX |
Cardlytics Inc |
Director |
|
2019-06-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(374,976) |
758,165 |
0 |
- |
|
CDLX |
Cardlytics Inc |
Director |
|
2019-07-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(570,482) |
187,683 |
0 |
- |
|
CDLX |
Cardlytics Inc |
Director |
|
2019-08-12 |
4 |
S |
$31.80 |
$5,991,633 |
D/D |
(187,683) |
0 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|